Management of primary malignant germ cell tumor of the mediastinum

Japanese Journal of Clinical Oncology

Volumn 34, Issue 7, 2004, Pages 386-392

  Sakurai, Hiroyuki ^a,b   Asamura, Hisao ^a   Suzuki, Kenji ^a   Watanabe, Shun Ichi ^a   Tsuchiya, Ryosuke ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Germ cell tumor; Mediastinal neoplasms; Mediastinum; Tumor markers

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; ETOPOSIDE; TUMOR MARKER;

ADULT; AGE; ARTICLE; CANCER RECURRENCE; CELL VIABILITY; CLINICAL ARTICLE; DRUG MEGADOSE; FEMALE; GERM CELL TUMOR; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; JAPAN; MALE; MEDIASTINUM CANCER; MULTIMODALITY CANCER THERAPY; NON SEMINOMATOUS GERMINOMA; OVERALL SURVIVAL; PREOPERATIVE TREATMENT; PROGNOSIS; RARE DISEASE; RETROSPECTIVE STUDY; SEMINOMA; SEX DIFFERENCE; SURGICAL TECHNIQUE; TREATMENT RESPONSE; ADJUVANT THERAPY; ADOLESCENT; MEDIASTINUM TUMOR; MIDDLE AGED; NEOPLASM; PATHOLOGY; SURVIVAL;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MEDIASTINAL NEOPLASMS; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASMS, GERM CELL AND EMBRYONAL; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 6044249944     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyh062     Document Type: Article

References (46)

1. Hainsworth JD, Greco FA. Extragonadal germ cell tumors and unrecognized germ cell tumors. Semin Oncol 1992;19:119-27.
2. Fine G, Smith RW, Pachter MR. Primary extragenital choriocarcinoma in male subject. Case report and review of the literature. Am J Med 1962;32: 776-94.
3. Nichols CR, Saxman S, Williams SD, Loehrer PJ, Miller ME, Wright C, et al. Primary mediastinal nonseminomatous germ cell tumors. A modern single institution experience. Cancer 1990;65:1641-6.
4. Walsh GL, Taylor GD, Nesbitt JC, Amato RJ. Intensive chemotherapy and radical resections for primary nonseminomatous mediastinal germ cell tumors. Ann Thorac Surg 2000;69:337-44.
5. Wychulis AR, Payne WS, Clagget OT, Woolner LB. Surgical treatment of mediastinal tumors: A 40-year experience. J Thorac Cardiovasc Surg 1971;62:379-92.
6. Wright CD, Kesler KA, Nichols CR, Mahomed Y, Einhorn LH, Miller ME, et al. Primary mediastinal nonseminomatous germ cell tumors. Results of a multimodality approach. J Thorac Cardiovasc Surg 1990;99: 210-7.
7. Dulmet EM, Macchiarini P, Suc B, Verley JM. Germ cell tumors of the mediastinum. A 30-year experience. Cancer 1993;72:1894-901.
8. Jyothirmayi R, Ramadas K, Jacob R, Gangadharan VP, Nair MK. Primary malignant germ cell tumours of the mediastinum. Results of multimodality treatment. Acta Oncol 1997;36:317-21.
9. Bajorin D, Katz A, Chan E, Geller N, Vogelzang N, Bosl GJ. Comparison of criteria for assigning germ cell tumor patients to 'good risk' and 'poor risk' studies. J Clin Oncol 1988;6:786-92.
10. Toner GC, Geller NL, Lin SY, Bosl GJ. Extragonadal and poor risk nonseminomatous germ cell tumors. Cancer 1991;67:2049-57.
11. Childs WJ, Goldstraw P, Nicholls JE, Dearnaley DP, Horwich A. Primary malignant mediastinal germ cell tumours: Improved prognosis with platinum-based chemotherapy and surgery. Br J Cancer 1993;67:1098-101.
12. Bukowski RM, Wolf M, Kulander BG, Montie J, Crawford ED, Blumenstein B. Alternating combination chemotherapy in patients with extragonadal germ cell tumors. A South West Oncology Group Study. Cancer 1993;71:2631-8.
13. Gerl A, Clemm C, Lamerz R, Wilmanns W. Cisplatin-based chemotherapy of primary extragonadal germ cell tumors. A single institution experience. Cancer 1996;77:526-32.
14. Moran CA, Suster S, Koss MN. Primary germ cell tumors of the mediastinum. III. Yolk sac tumor, embryonal carcinoma, choriocarcinoma, and combined nonteratomatous germ cell tumors of the mediastinum: A clinicopathologic and immunohistochemical study of 64 cases. Cancer 1997; 80:699-707.
15. International Germ Cell Cancer Collaborative Group. International germ cell consensus classification: A prognostic factor-based staging system for metastatic germ cell cancers. J Clin Oncol 1997;15:594-603.
16. Toner GC, Motzer RJ. Poor prognosis germ cell tumors: Current status and future directions. Semin Oncol 1998;25:194-202.
17. Logothetis CJ, Samuels ML, Selig DE, Dexeus FH, Johnson DE, Swanson DA, et al. Chemotherapy of extragonadal germ cell tumors. J Clin Oncol 1985;3:316-25.
18. Williams SD, Birch R, Einhorn LH, Irwin L, Greco FA, Loehrer PJ. Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vunblastine or etoposide. N Engl J Med 1987;316:1435-40.
19. Loehrer P, Birch R, Williams SD, Greco FA, Einhorn LH. Chemotherapy of metastatic seminoma: The Southeastern Cancer Study Group Experience. J Clin Oncol 1987;8:1212-20.
20. Nichols CR, Andersen J, Lazarus HM, Fisher H, Greer J, Stadtmauer EA, et al. High-dose carboplatin and etoposide with autologous bone marrow transplantation in refractory germ cell cancer: An Eastern Cooperative Oncology Group Protocol. J Clin Oncol 1992;10:558-63.
21. Motzer RJ, Mazumdar M, Gulati SC, Bajorin DF, Lyn P, Vlamis V, et al. Phase II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors. J Natl Cancer Inst 1993;85:1828-35.
22. Motzer RJ, Mazumdar M, Bosl GJ, Bajorin DF, Amsterdam A, Vlamis V. High-dose carboplatin, etoposide, and cyclophosphamide for patients with refractory germ cell tumors: Treatment results and prognostic factors for survival and toxicity. J Clin Oncol 1996;14:1098-105.
23. Shepherd FA, Ginsberg R, Patterson GA, Feld R, Goss PE, Pearson FG, et al. Is there ever a role for salvage operations in limited small-cell lung cancer? J Thorac Cardiovasc Surg 1991;101:196-200.
24. Asamura H, Tsuchiya R, Goya T, Kondo H, Naruke T, Saijo N, et al. Malignant germ cell tumor of the mediastinum: A multimodality therapeutic approach. Surg Today 1994;24:137-141.
25. Goss PE, Schwertfeger L, Blackstein ME, Iscoe NA, Ginsberg RJ, Simpson WJ, et al. Extragonadal germ cell tumors. A 14-year Toronto experience. Cancer 1994;73:1971-9.
26. Hainsworth JD, Einhorn LH, Williams SD, Stewart M, Greco FA. Advanced extragonadal germ cell tumors. Successful treatment with combination chemotherapy. Ann Intern Med 1982;97:7-11.
27. Nichols CR, Heerema NA, Palmer C, Loehrer PJ, Williams SD, Einhorn LH. Klinefelter's syndrome associated with mediastinal germ cell neoplasms. J Clin Oncol 1987;5:1290-4.
28. Hasle H, Jacobsen BB, Asschenfeldt P, Andersen K. Mediastinal germ cell tumour associated with Klinefelter syndrome. A report of case and review of the literature. Eur J Pediatr 1992;151:735-9.
29. Jain KK, Bosl GJ, Bains MS, Whitmore WF, Golbey RB. The treatment of extragonadal seminoma. J Clin Oncol 1984;7:820-7.
30. Ganjoo KN, Rieger KM, Kesler KA, Sharma M, Heilman DK, Einhorn LH. Results of modern therapy for patients with mediastinal nonseminomatous germ cell tumors. Cancer 2000;88:1051-6.
31. Takeda S, Miyoshi S, Ohta M, Minami M, Masaoka A, Matsuda H. Primary germ cell tumors in the mediastinum. A 50-year experience at a single Japanese institution. Cancer 2003;97:367-6.
32. Bosl GJ, Geller NL, Cirrincione C, Vogelzang NJ, Kennedy BJ, Whitmore WF, et al. Multivariate analysis of prognostic variables in patients with metastatic testicular cancer. Cancer Res 1983;43:3403-7.
33. Kesler KA, Rieger KM, Ganjoo KN, Sharma M, Fineberg NS, Einhorn LH, et al. Primary mediastinal nonseminomatous germ cell tumors: The influence of postchemotherapy pathology on long-term survival after surgery. J Thorac Cardiovasc Surg 1999;118:692-701.
34. Tait D, Peckham MJ, Hendry WF, Goldstraw P. Post-chemotherapy surgery in advanced non-seminomatous germ-cell testicular tumours: The significance of histology with particular reference to differentiated (mature) teratoma. Br J Cancer 1984;50:601-9.
35. Motzer RJ, Bosl GJ. Chemotherapy for germ cell tumors. Urol Clin North Am 1987;14:389-98.
36. Motzer RJ, Geller NL, Tan CC, Herr H, Morse M, Fair W, et al. Salvage chemotherapy for patients with germ cell tumors. The Memorial Sloan-Kettering Cancer Center experience (1979-1989). Cancer 1991;67:1305-10.
37. Vuky J, Bains M, Bacik J, Higgins G, Bajorin DF, Mazumdar M, et al. Role of postchemotherapy adjunctive surgery in the management of patients with nonseminoma arising from the mediastinum. J Clin Oncol 2001;19:682-8.
38. Murphy BR, Breeden ES, Donohue JP, Messemer J, Walsh W, Roth BJ, et al. Surgical salvage of chemorefractory germ cell tumors. J Clin Oncol 1993;11:324-9.
39. Afifi HY, Bosl GJ, Burt ME. Mediastinal growing teratoma syndrome. Ann Thorac Surg 1997;64:359-62.
40. Economou JS, Trump DL, Holmes EC, Eggleston JE. Management of primary germ cell tumors of the mediastinum. J Thorac Cardiovasc Surg 1982;83:643-9.
41. Knapp RH, Hurt RD, Payne WS, Farrow GM, Lewis BD, Hahn RG, et al. Malignant germ cell tumors of the mediastinum. J Thorac Cardiovasc Surg 1985;89:82-9.
42. Moran CA, Suster S, Przygodzki RM, Koss MN. Primary germ cell tumors of the mediastinum. II. Mediastinal seminomas: A clinicopathologic and immunohistochemical study of 120 cases. Cancer 1997;80:691-8.
43. Motzer R, Bosl G, Heelan R, Fair W, Whitmore W, Sogani P, et al. Residual mass: An indication for further therapy in patients with advanced seminoma following systemic chemotherapy. J Clin Oncol 1987;7:1064-70.
44. Ozols RF, Ihde DC, Linehan WM, Jacob J, Ostchega Y, Young RC. A randomized trial of standard chemotherapy v a high-dose chemotherapy regimen in the treatment of poor prognosis nonseminomatous germ-cell tumors. J Clin Oncol 1988;6:1031-40.
45. Broun ER, Nichols CR, Einhorn LH, Tricot GJK. Salvage therapy with high-dose chemotherapy and autologous bone marrow support in the treatment of primary nonseminomatous mediastinal germ cell tumors. Cancer 1991;68:1513-5.
46. Saxman SB, Nichols CR, Einhorn LH. Salvage chemotherapy in patients with extragonadal nonseminomatous germ cell tumors: The Indiana University experience. J Clin Oncol 1994;12:1390-3.